PTC Granted Marketing Authorization by European Commission for AADC Deficiency Treatment August 1, 2022 AutoBot News 0 The European Commission has granted marketing authorization to Upstaza (eladocagene exuparvovec) for treatment of aromatic L-amino acid decarboxylase (AADC) deficiency.